ERBB2 and breast carcinoma: Functionally, breast cancer-associated fibroblasts derived from HER2+ breast cancers significantly enhanced the transwell migration of the T47D breast cancer cell line, as compared to the fibroblasts isolated from ER+ or triple-negative breast cancers.